Fig. 1.

Study design. Mice were assigned to five groups (control, RT alone, RT+CT, RT+DC and RT+CT+DC) in the study. MCA102 cells were inoculated subcutaneously in the upper right flank of a C57BL/6 mouse. On day 10, when the average tumor size reached about 4~5 mm in diameter, paclitaxel was intraperitoneally administered and RT was performed 6 hours later. The same treatment was administered on two more days; day 12 and day 14. DCs were injected intratumorally four times on days 11, 13, 15 and 18. RT: radiotherapy, CT: chemotherapy, DC: dendritic cell.